Impfstoff gegen Bordetella pertussis

Patent europeic · EP0352250 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP0352250
Numer da la dumonda
EP89870113
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
20-07-1989
Publitgà
24-01-1990
Concedì
11-09-1996
Stritgà
19-07-2009
Motiv
Durada maximala cuntanschida
Classas IPC
C12N 15/31 (2006.01)
C12P 21/00 (2006.01)
A61K 39/10 (2006.01)
Prioritad
US 222991 22.07.1988
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 27-07-2009

    Durada maximala cuntanschida

    Published in Swissreg on 27.07.2009

  2. 30-06-2008

    Adressa midada

    Representative
    A. Braun, Braun, Héritier,, Eschmann AG, Patentanwälte, Holbeinstrasse 36-38, 4051 Basel → BOHEST AG, Postfach 160, 4003 Basel

    Published in +pat+ No 12 in 2008

  3. 29-11-1996

    Represchentant inscrit

    Representative
    A. Braun, Braun, Héritier,, Eschmann AG, Patentanwälte, Holbeinstrasse 36-38, 4051 Basel

    Published in PIDTJ No 22 in 1996

  4. 13-09-1996

    Concedì

    Published in PIDTJ No 17 in 1996

Partidas

Possessur

SmithKline Beecham Biologicals S.A.

Rue de l'Institut 89, 1330 Rixensart, BE

Represchentant

BOHEST AG

Postfach 160, 4003 Basel

Inventur

Capiau, Carine

B-7092 Mons, BE

Locht, Camille

B-1320 Genval (Rixensart), BE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.